| Medical and Health Sciences | 2021-2025 | 993 | CZ 3 | 99.76 |
| Nephrology | Lifetime | 118 | CZ 1 | 99.10 |
| Pulmonary and Respiratory Medicine | Lifetime | 684 | CZ 1 | 98.98 |
| Rheumatology | Lifetime | 669 | CZ 2 | 96.64 |
| Clinical Biochemistry | Lifetime | 796 | CZ 1 | 79.14 |
| Nephrology | 2021-2025 | 21 | CZ 1 | 99.54 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 264 | CZ 1 | 97.76 |
| Rheumatology | 2021-2025 | 410 | CZ 2 | 81.58 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 683 | CZ 1 | 61.07 |
| Renal Diseases and Glomerulopathies | Lifetime | 51 | CZ 1 | 99.55 |
| Vasculitis and related conditions | Lifetime | 32 | CZ 1 | 99.48 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 110 | CZ 1 | 98.72 |
| Systemic Lupus Erythematosus Research | Lifetime | 485 | CZ 1 | 98.49 |
| Chronic Kidney Disease and Diabetes | Lifetime | 271 | CZ 1 | 98.46 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 65 | CZ 1 | 97.91 |
| Genetic and Kidney Cyst Diseases | Lifetime | 279 | CZ 1 | 96.06 |
| Autoimmune Bullous Skin Diseases | Lifetime | 598 | CZ 1 | 96.08 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 331 | CZ 2 | 95.66 |
| Platelet Disorders and Treatments | Lifetime | 921 | CZ 1 | 95.87 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 674 | CZ 2 | 93.60 |
| Advanced Glycation End Products research | Lifetime | 744 | CZ 5 | 92.45 |
| Complement system in diseases | Lifetime | 896 | CZ 1 | 93.57 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 5 | CZ 1 | 99.79 |
| Vasculitis and related conditions | 2021-2025 | 9 | CZ 1 | 99.32 |
| Platelet Disorders and Treatments | 2021-2025 | 40 | CZ 1 | 97.97 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 30 | CZ 1 | 97.86 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 74 | CZ 1 | 97.89 |
| Complement system in diseases | 2021-2025 | 55 | CZ 1 | 96.33 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 170 | CZ 1 | 94.19 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 494 | CZ 1 | 93.36 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 227 | CZ 1 | 79.38 |
| Genetic and Kidney Cyst Diseases | 2021-2025 | 427 | CZ 4 | 77.47 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 288 | CZ 1 | 76.56 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 898 | CZ 1 | 76.53 |
